Učitavanje...
Potential new uses of non–vitamin K antagonist oral anticoagulants to treat and prevent stroke
BACKGROUND: Non–vitamin K antagonist oral anticoagulant (NOAC) drugs are at least equivalent to warfarin for ischemic stroke prevention in patients with atrial fibrillation and have a lower risk of intracranial hemorrhage. The role of these agents in the prevention and treatment of other types of ce...
Spremljeno u:
| Izdano u: | Neurology |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Lippincott Williams & Wilkins
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4603598/ https://ncbi.nlm.nih.gov/pubmed/26187229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001817 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|